(Q38242945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

2 references

25 January 2021

8 February 2021

Berberine, an epiphany against cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

phytogenic antineoplastic agents

13 March 2020

main subject

1 reference

25 January 2021

1 reference

8 February 2021

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Anna Ivana Scovassi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Luis Miguel Guamán Ortiz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Micol Tillhon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

English

0 references

publication date

15 August 2014

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

25 January 2021

8 February 2021

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

25 January 2021

8 February 2021

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

12349-12367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

13 March 2020

copyright license

1 reference

8 February 2021

0 references

Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Anti-inflammatory and anticancer drugs from nature

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Traditional Chinese medicine ZHENG and Omics convergence: a systems approach to post-genomics medicine in a global world

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Natural compounds as anticancer agents: Experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Interaction of herbal compounds with biological targets: a case study with berberine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine: new perspectives for old remedies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Antinociceptive effect of berberine on visceral hypersensitivity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of berberine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine represses DAXX gene transcription and induces cancer cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Comprehensive study in the inhibitory effect of berberine on gene transcription, including TATA box

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine inhibited the growth of thyroid cancer cell lines 8505C and TPC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Multiple effects of berberine derivatives on colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Antitumor effect of novel berberine derivatives in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Endoplasmic reticulum stress mediating downregulated StAR and 3-beta-HSD and low plasma testosterone caused by hypoxia is attenuated by CPU86017-RS and nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E₂ and prostaglandin E₂ receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Telomerase at the intersection of cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The role of telomeres in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine acts as a natural inhibitor of Wnt/β-catenin signaling--identification of more active 13-arylalkyl derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The interplay of AMP-activated protein kinase and androgen receptor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

AMP-activated protein kinase: An emerging target for ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The catalytic mechanism and structure of thymidylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Update on antifolate drugs targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Inhibition of activator protein 1 activity by berberine in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The anti-inflammatory potential of berberine in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Enhancement of Arsenic Trioxide (As(2)O(3))- Mediated Apoptosis Using Berberine in Human Neuroblastoma SH-SY5Y Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The combinational effect of vincristine and berberine on growth inhibition and apoptosis induction in hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine Reduces the Metastasis of Chondrosarcoma by Modulating the α v β 3 Integrin and the PKC δ , c-Src, and AP-1 Signaling Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The autophagic paradox in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The four faces of autophagy: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The paradox of autophagy and its implication in cancer etiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Self-consumption: the interplay of autophagy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

The variability of autophagy and cell death susceptibility: Unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Killing of tumor cells: a drama in two acts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine hydrochloride: anticancer activity and nanoparticulate delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Conversation between apoptosis and autophagy: "Is it your turn or mine?".

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Quaternary protoberberine alkaloids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine and its derivatives: a patent review (2009 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Aromatic interactions in model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

On the importance and origin of aromatic interactions in chemistry and biodisciplines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Biophysical studies on the effect of the 13 position substitution of the anticancer alkaloid berberine on its DNA binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Set9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190812349

Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity

21 January 2018

1 reference

12 December 2020

Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells

1 reference

12 December 2020

The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition

1 reference

12 December 2020

Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells.

1 reference

12 December 2020

Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3.

1 reference

12 December 2020

Inhibition of DNA topoisomerase I by natural and synthetic mono- and dimeric protoberberine alkaloids

1 reference

12 December 2020

Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway

1 reference

12 December 2020

GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells.

1 reference

12 December 2020

Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis.

1 reference

12 December 2020

Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.

1 reference

12 December 2020

Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells

1 reference

12 December 2020

Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells

1 reference

12 December 2020

The interaction of telomeric DNA and C-myc22 G-quadruplex with 11 natural alkaloids

1 reference

12 December 2020

Berberine induces apoptosis via the mitochondrial pathway in liver cancer cells.

1 reference

12 December 2020

Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells.

1 reference

12 December 2020

Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer.

1 reference

12 December 2020

Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF‑κB

1 reference

12 December 2020

Spectroscopic studies on the binding interaction of novel 13-phenylalkyl analogs of the natural alkaloid berberine to nucleic acid triplexes

1 reference

12 December 2020

The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review).

1 reference

12 December 2020

TRAIL combinations: The new 'trail' for cancer therapy (Review).

1 reference

12 December 2020

BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer

1 reference

12 December 2020

Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes

1 reference

12 December 2020

Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne.

1 reference

12 December 2020

Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs

1 reference

12 December 2020

Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine

1 reference

12 December 2020

10.3390/MOLECULES190812349

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153862%20AND%20SRC:MED&resulttype=core&format=json